PLSE Pulse Biosciences, Inc.

NASDAQ
$51.63

Pulse Biosciences, Inc. (PLSE) is expected to report earnings on November 9, 2026, after the market close. The consensus earnings estimate is a loss of $0.35 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +36.4% since its last earnings release on August 6, 2026.

Pulse Biosciences Missed Consensus Estimates
Thursday, August 6, 2026 · 4:05 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 9
Monday · 4:05 PM ET
Earnings Whisper
-
vs ($0.35)
Rev est $1M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $50.13

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Pulse Biosciences, Inc.

Pulse Biosciences is a novel bioelectric medicine company committed to health innovation that has the potential to improve the quality of life for patients.

Sector

Healthcare

Industry

Medical Instruments/Supply

Held By 2 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.